The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-12 of 12 articles
Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation: one-year results from the ILUMIEN III: OPTIMIZE PCI trial
Ali Z,
Karimi Galougahi K,
Maehara A,
Shlofmitz R,
Fabbiocchi F,
Guagliumi G,
Alfonso F,
Akasaka T,
Matsumura M,
Mintz G,
Ben-Yehuda O,
Zhang Z,
Rapoza R,
West N,
Stone G
January 20, 2021 | 10.4244/EIJ-D-20-00498
Optical coherence tomography-guided coronary stent implantation compared to angiography: a multicentre randomised trial in PCI – design and rationale of ILUMIEN IV: OPTIMAL PCI
Ali Z,
Landmesser U,
Karimi Galougahi K,
Maehara A,
Matsumura M,
Shlofmitz R,
Guagliumi G,
Price M,
Hill J,
Akasaka T,
Prati F,
Bezerra H,
Wijns W,
Mintz G,
Ben-Yehuda O,
McGreevy R,
Zhang Z,
Rapoza R,
West N,
Stone G
January 20, 2021 | 10.4244/EIJ-D-20-00501
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabaté M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE-ABSORB randomised clinical trial
Smits P,
Chang C,
Chevalier B,
West N,
Gori T,
Barbato E,
Tarantini G,
Kocka V,
Achenbach S,
Dudek D,
Escaned J,
Wlodarczak A,
Abdel-Wahab M,
Esposito G,
Tijssen J,
Morice M,
Onuma Y,
van Geuns R
October 23, 2020 | 10.4244/EIJ-D-19-01079
Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: the ABSORB UK Registry
Baumbach A,
Zaman A,
West N,
O'Kane P,
Egred M,
Johnson T,
Wheatcroft S,
Bowles R,
de Belder A,
Bouras G,
Lansky A,
Hill J,
Mathur A,
De Belder M,
Banning A
January 19, 2018 | 10.4244/EIJ-D-17-00886
Cholesterol crystals identified using optical coherence tomography and virtual histology intravascular ultrasound
June 19, 2015 | 10.4244/EIJV11I2A38
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Weissman N,
Barragan P,
Scott D,
Valdés Chávarri M,
West N,
Kelbæk H,
Whitbourn R,
Walters D,
Kubica J,
Thuesen L,
Masotti M,
Banning A,
Sjogren I,
Stables R,
Allocco DJ,
Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study
Danzi G,
Chevalier B,
Urban P,
Fath-Ordoubadi F,
Carrié D,
Wiemer M,
Serra A,
Wijns W,
Kala P,
Stabile A,
Ruigomez J,
Sagic D,
Laanmets P,
Strupp G,
West N,
Paunovic D
May 15, 2012 | 10.4244/EIJV8I1A17
Myocardial Injury following Coronary Artery Surgery versus Angioplasty (MICASA): a randomised trial using biochemical markers and cardiac magnetic resonance imaging
van Gaal W,
Arnold J,
Testa L,
Karamitsos T,
Lim C,
Ponnuthurai F,
Petersen S,
Francis J,
Selvanayagam J,
Sayeed R,
West N,
Westaby S,
Neubauer S,
Banning A
January 20, 2011
Latest news
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
AHEAD OF PRINT
Navitor CE mark cohort outcomes
FREE ARTICLE - Lars Sondergaard et al
March 9, 2023
AHEAD OF PRINT
One-year SAPIEN 3U registry results
FREE ARTICLE - Stefano Cannata et al
March 7, 2023
AHEAD OF PRINT
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation
FREE ARTICLE - Farhang Aminfar et al
March 3, 2023